Exact Mass: 496.28247400000004
Exact Mass Matches: 496.28247400000004
Found 500 metabolites which its exact mass value is equals to given mass value 496.28247400000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Absinthin
Absinthin is a dimeric sesquiterpene lactone that is produced by the plant Artemisia absinthium (Wormwood). The bitter tasting constituent of Absinthe. It has a role as a plant metabolite and an anti-inflammatory agent. It is a sesquiterpene lactone, a triterpenoid and an organic heteroheptacyclic compound. Absinthin is a natural product found in Artemisia genipi, Artemisia annua, and other organisms with data available. Constituent of Artemisia absinthium (wormwood). Isoabsinthin is found in alcoholic beverages and herbs and spices. Isoabsinthin is found in alcoholic beverages. Isoabsinthin is a constituent of Artemisia absinthium (wormwood).
Leukotriene D4
C25H40N2O6S (496.26069400000006)
Leukotriene D4 (LTD4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. LTD4 is a pro-inflammatory mediator known to mediate its effects through specific cell-surface receptors belonging to the G-protein-coupled receptor family, namely the high-affinity CysLT1 (cysteinyl leukotriene 1) receptor. LTD4 is present at high levels in many inflammatory conditions, and areas of chronic inflammation have an increased risk for subsequent cancer development. LTD4 is associated with the pathogenesis of several inflammatory disorders, such as asthma and inflammatory bowel disease. Exposure to LTD4 increases survival and proliferation in intestinal epithelial cells. CysLT1 regulator is up-regulated in colon cancer tissue and LTD4 signalling facilitates the survival of cancer cells. LTD4 could reduce apoptosis in non-transformed epithelial cells. LTD4 causes up-regulation of beta-catenin through the CysLT1 receptor, PI3K (phosphoinositide 3-kinase), and GSK-3β (glycogen synthase kinase 3β). LTD4 induces beta-catenin translocation to the nucleus and activation of TCF/LEF family of transcription factors. LTD4 causes accumulation of free beta-catenin in non-transformed intestinal epithelial cells through the CysLT1 receptor, and this accumulation is dependent upon the activation of PI3K as well as GSK-3β inactivation (PMID: 16042577, 12607939). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent and are able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis through receptor-mediated G-protein linked signaling pathways. Leukotriene D4 (LTD4) is a cysteinyl leukotriene a family of potent inflammatory mediators. LTD4 is a pro-inflammatory mediator known to mediate its effects through specific cell-surface receptors belonging to the G-protein-coupled receptor family, namely the high-affinity CysLT1 (cysteinyl leukotriene 1) receptor. LTD4 is present at high levels in many inflammatory conditions, and areas of chronic inflammation have an increased risk for subsequent cancer development; LTD4 is associated with the pathogenesis of several inflammatory disorders, such as asthma and inflammatory bowel disease. Exposure to LTD4 increases survival and proliferation in intestinal epithelial cells. CysLT1 regulator is up-regulated in colon cancer tissue and LTD4 signalling facilitates the survival of cancer cells. LTD4 could reduce apoptosis in non-transformed epithelial cells. LTD4 causes up-regulation of b-catenin through the CysLT1 receptor, PI3K (phosphoinositide 3-kinase) and GSK-3b (glycogen synthase kinase 3b). LTD4 induces b-catenin translocation to the nucleus and activation of TCF/LEF family of transcription factors. LTD4 causes accumulation of free b-catenin in non-transformed intestinal epithelial cells through the CysLT1 receptor, and this accumulation is dependent upon the activation of PI3K as well as GSK-3b inactivation. (PMID: 16042577, 12607939)
Fexaramine
ST 27:2;O8
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
G-418
C20H40N4O10 (496.27443000000005)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
Pregnanediol-3-glucuronide
Pregnanediol 3-O-glucuronide is a natural human metabolite of pregnanediol generated in the liver by UDP glucuronyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs, or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Pregnanediol 3-O-glucuronide has been identified in the human placenta (PMID: 32033212). Pregnanediol-3-glucuronide is a natural human metabolite of Pregnanediol generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(3b,16b,20R)-Pregn-5-ene-3,16,20-triol 3-glucoside
(3b,16b,20R)-Pregn-5-ene-3,16,20-triol 3-glucoside is found in fruits. (3b,16b,20R)-Pregn-5-ene-3,16,20-triol 3-glucoside is a constituent of Balanites aegyptiaca (soapberry tree fruits). Constituent of Balanites aegyptiaca (soapberry tree fruits). (3b,16b,20R)-Pregn-5-ene-3,16,20-triol 3-glucoside is found in fruits.
Anabsinthin
Isolated from Artemisia absinthium (wormwood). Anabsinthin is found in alcoholic beverages and herbs and spices. Anabsinthin is found in alcoholic beverages. Anabsinthin is isolated from Artemisia absinthium (wormwood).
Postin
C22H40N8O5 (496.31215100000003)
Postin (Lys-Pro-Pro-Arg) is the N-terminal tetrapeptide of cystatin C and an antagonist of tuftsin. [HMDB] Postin (Lys-Pro-Pro-Arg) is the N-terminal tetrapeptide of cystatin C and an antagonist of tuftsin.
APGPR Enterostatin
Enterostatin APGPR (Ala-Pro-Gly-Pro-Arg) is a pentapeptide released from procolipase during fat digestion. In addition to the pancreas, enterostatin-immunoreactive cells are also present in the antrum and proximal small intestine. Enterostatin selectively reduces fat intake, decreases insulin secretion, and also increases energy expenditure by activating brown adipose tissue during high-fat feeding. Enterostatins are pentapeptides derived from the NH2-terminus of procolipase after tryptic cleavage and belong to the family of gut-brain peptides. Enterostatin is generated by the action of trypsin on procolipase in the intestinal lumen. Its structure is highly conserved in evolution, with an amino acid sequence of XPXPR. Three enterostatin sequences, Val-Pro-Asp-Pro-Arg (VPDPR), Val-Pro-Gly-Pro-Arg (VPGPR), and Ala-Pro-Gly-Pro-Arg (APGPR), have been studied extensively and shown to be almost equally effective in their ability to decrease dietary fat preference. Enterostatins are selective inhibitors of appetite, particularly of fat intake. Hyperenterostatinemia in obesity is probably secondary to enterostatin resistance; therefore, the regulatory system is producing more enterostatin to counteract the resistance. This is very similar to hyperinsulinemia and hyperleptinemia in obesity. The diminution in the meal-induced secretion of enterostatin in obesity suggests a delay in the appearance of satiety, leading to increased caloric intake. In rats enterostatin decreases body weight by decreasing fat-calorie intake and increasing the sympathetic firing rate of the nerves in interscapular brown adipose tissue. Enterostatin levels are elevated in the plasma of obese women, and enterostatin secretion is diminished after satiety. Oral administration of enterostatin, however, has no effect on food intake, energy expenditure, or body weight in subjects with a preference for a high-fat diet experiencing a negative energy and fat balance, and the physiology of enterostatin in humans remains to be defined. (PMID: 10084574, 9526102, 8886249) [HMDB] Enterostatin APGPR (Ala-Pro-Gly-Pro-Arg) is a pentapeptide released from procolipase during fat digestion. In addition to the pancreas, enterostatin-immunoreactive cells are also present in the antrum and proximal small intestine. Enterostatin selectively reduces fat intake, decreases insulin secretion, and also increases energy expenditure by activating brown adipose tissue during high-fat feeding. Enterostatins are pentapeptides derived from the NH2-terminus of procolipase after tryptic cleavage and belong to the family of gut-brain peptides. Enterostatin is generated by the action of trypsin on procolipase in the intestinal lumen. Its structure is highly conserved in evolution, with an amino acid sequence of XPXPR. Three enterostatin sequences, Val-Pro-Asp-Pro-Arg (VPDPR), Val-Pro-Gly-Pro-Arg (VPGPR), and Ala-Pro-Gly-Pro-Arg (APGPR), have been studied extensively and shown to be almost equally effective in their ability to decrease dietary fat preference. Enterostatins are selective inhibitors of appetite, particularly of fat intake. Hyperenterostatinemia in obesity is probably secondary to enterostatin resistance; therefore, the regulatory system is producing more enterostatin to counteract the resistance. This is very similar to hyperinsulinemia and hyperleptinemia in obesity. The diminution in the meal-induced secretion of enterostatin in obesity suggests a delay in the appearance of satiety, leading to increased caloric intake. In rats enterostatin decreases body weight by decreasing fat-calorie intake and increasing the sympathetic firing rate of the nerves in interscapular brown adipose tissue. Enterostatin levels are elevated in the plasma of obese women, and enterostatin secretion is diminished after satiety. Oral administration of enterostatin, however, has no effect on food intake, energy expenditure, or body weight in subjects with a preference for a high-fat diet experiencing a negative energy and fat balance, and the physiology of enterostatin in humans remains to be defined. (PMID: 10084574, 9526102, 8886249). Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake. Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake.
3-alpha,20-alpha-Dihydroxy-5-beta-pregnane 3-glucuronide
3-alpha,20-alpha-dihydroxy-5-beta-pregnane 3-glucuronide is a natural human metabolite of 3-alpha,20-alpha-dihydroxy-5-beta-pregnane generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
geneticin
C20H40N4O10 (496.27443000000005)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
6-[2-Amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
C25H40N2O6S (496.26069400000006)
20,26-Dihydroxyecdysone
Fexaramine
Polypodine B
Polypodine b belongs to hydroxy bile acids, alcohols and derivatives class of compounds. Those are bile acids, alcohols or derivatives bearing at least hydroxyl group. Polypodine b is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Polypodine b can be found in lambsquarters and spinach, which makes polypodine b a potential biomarker for the consumption of these food products.
Prochaetoglobosin II
A cytochalasan alkaloid found in Chaetomium globosum and Chaetomium subaffine.
2-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-5-oxido-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-5-ium
C29H40N2O5 (496.29370700000004)
(7a,17R,20R)-7-hydroxy-23,26-epoxy-3,4-secocycloarta-4(28),23(24),25(26)-trien-3-oic acid 6,29-lactone|dikamaliartane E
O-beta-D-Glucopyranoside-(ent-11alpha,16alpha)-11-Hydroxy-15-oxo-kauranoic acid
12-O-beta-D-glucopyranosyl-3,11,16-trihydroxyabieta-8,11,13-triene
(3aS,13aXi)-12t,14c-Dihydroxy-1t,4,6,9c,12c,14t-hexamethyl-(3ar,3bxi,5axi,6bt,9ac,16at)-Delta4,6a(12a)-tetradecahydro-3,7-dioxa-6xi,13xi-methano-indeno[1,7a-e;5,6-e]diazulen-2,8-dion|(3aS,13aXi)-12t,14c-dihydroxy-1t,4,6,9c,12c,14t-hexamethyl-(3ar,3bxi,5axi,6bt,9ac,16at)-Delta4,6a(12a)-tetradecahydro-3,7-dioxa-6xi,13xi-methano-indeno[1,7a-e;5,6-e]diazulene-2,8-dione
18-O-beta-D-glucopyranosyl,19-hydroxy-5alpha,10beta-neo-cleroda-3,13(14)-dien-16,15-butenolide|soulidioside
(20alpha)-2,3-dihydroxy-6,23-dioxo-24-nor-friedela-1(10),3,5,7-tetraen-carboxylic acid-(29)-methylester|macrocarpin A
5beta-myrtenyl-4alpha,5-dihydroatripliciolide-8-O-isovalerate
(-)-19-beta-D-glucopyranosyl 6,7-dihydroxy-kaurenoate
methyl 7,10,11-trihydroxy-2,4a,6a,6a,9,14a-hexamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate
16alpha-acetoxy-5beta,6beta-epoxy-1-oxowitha-2,24-dienolide
(25R)-5beta-spirostane-1beta,2beta,3beta,4beta,5beta,6beta-hexol
3alpha-hydroxy-1,7,11-trioxolanosta-8,24-dien-26,23R-olide
(1S*,2S*,3S*,4R*,4aR*,5R*,6R*,9R*,10S*,12R*,12aS*)-tetradecahydro-1,6,10-trimethyl-4-(1-methylethyl)-5,12:6,9-diepoxybenzocyclododecene-1,2,3,9-tetrol 1,2,3-triacetate|massileunicellin C
1-O-decanoyl-6-O-D-beta-glucopyranosyl-beta-D-glucopyranose|6-O-(beta-D-glucopyranosyl)-1-O-decanoyl-beta-D-glucopyranose|nonioside R
C22H40O12 (496.25196400000004)
13S-hydroxy-labda-7,14-dien-6-oxo-19-oic acid beta-D-glucopyranoside|cathargyroside A
beta-D-glucopyranosyl (13S)-13-hydroxy-7-oxo-labda-8,14-diene-18-oate
15-hydroxy-labda-7,13E-dien-6-oxo-19-oic acid beta-D-glucopyranoside|cathargyroside B
6-methoxy-1-[5-methoxy-2-(5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-indol-3-ylmethyl]-2,3,4,9-tetrahydro-1H-beta-carboline|Cinchophyllamin|Isocinchophyllamin
12beta-acetoxy-4-deoxy-5,6-deoxy-Delta5-withanolide D
macropodumine J|methyl rel-(3R,6R,10aS,11S,12aS)-5-(acetyloxy)-5a-[(acetyloxy)methyl]-12b-cyano-2,3,3a,5,5a,6,7,8,9,10,10a,11,12,12b-tetradecahydro-3-methyl-4H-1,6-methanocyclopenta[1,8]azuleno[4,3a-g]indole-11-carboxylate
triptohypol A
A pentacyclic triterpenoid with formula C30H40O6, originally isolated from Tripterygium hypoglaucum.
(16S)-dihydrohyalic acid beta-glucopyranosyl ester
3-O-(2-methylbutyryl-5-O-isobutyryl)-4-O-decanoyl-shikimic acid methyl ester|3-O-<2-methylbutyryl-5-O-isobutyryl>-4-O-decanoyl-shikimic acid methyl ester
Val His Ile Glu
muristerone
Muristerone a is a natural product found in Gomphrena globosa, Gomphrena serrata, and other organisms with data available.
Turkesterone
Turkesterone is a steroid. Turkesterone is a natural product found in Sida spinosa, Cyanotis arachnoidea, and other organisms with data available. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones SubCategory_DNP: : The sterols, Cholestanes
Andropanoside
Andropanoside is a natural product found in Andrographis paniculata with data available.
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 8-methylnonanoate
C22H40O12 (496.25196400000004)
2,3,14-trihydroxy-10,13-dimethyl-17-(2,3,6,7-tetrahydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
C26H40O9_2,4a,6-Trihydroxy-8-isopropyl-1,1-dimethyl-2,3,4,4a,5,10,11,11a-octahydro-1H-dibenzo[a,d][7]annulen-7-yl beta-D-glucopyranoside
LTD4-[d5]
C25H40N2O6S (496.26069400000006)
CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0222.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0222.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0222.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0000153.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 8-methylnonanoate [IIN-based on: CCMSLIB00000846747]
C22H40O12 (496.25196400000004)
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 8-methylnonanoate [IIN-based: Match]
C22H40O12 (496.25196400000004)
Geneticin
C20H40N4O10 (496.27443000000005)
An aminoglycoside antibiotic produced by Micromonospora rhodorangea. It blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells.
2-[(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-3-ethyl-9,10-dimethoxy-5-oxido-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-5-ium_major
C29H40N2O5 (496.29370700000004)
Ala Phe Phe Ile
Ala Phe Phe Leu
Ala Phe Ile Phe
Ala Phe Leu Phe
Ala His Asn Arg
Ala His Arg Asn
Ala Ile Phe Phe
Ala Leu Phe Phe
Ala Asn His Arg
Ala Asn Arg His
Ala Arg His Asn
Ala Arg Asn His
Asp His Ile Ile
Asp His Ile Leu
Asp His Leu Ile
Asp His Leu Leu
Asp Ile His Ile
Asp Ile His Leu
Asp Ile Ile His
Asp Ile Leu His
Asp Leu His Ile
Asp Leu His Leu
Asp Leu Ile His
Asp Leu Leu His
Glu His Ile Val
Glu His Leu Val
Glu His Val Ile
Glu His Val Leu
Glu Ile His Val
Glu Ile Val His
Glu Leu His Val
Glu Leu Val His
Glu Val His Ile
Glu Val His Leu
Glu Val Ile His
Glu Val Leu His
Phe Ala Phe Ile
Phe Ala Phe Leu
Phe Ala Ile Phe
Phe Ala Leu Phe
Phe Phe Ala Ile
Phe Phe Ala Leu
Phe Phe Ile Ala
Phe Phe Leu Ala
Phe Ile Ala Phe
Phe Ile Phe Ala
Phe Leu Ala Phe
Phe Leu Phe Ala
Gly His Lys Arg
Gly His Gln Arg
Gly His Arg Lys
Gly His Arg Gln
Gly Lys His Arg
Gly Lys Arg His
Gly Gln His Arg
Gly Gln Arg His
Gly Arg His Lys
Gly Arg His Gln
Gly Arg Lys His
Gly Arg Gln His
His Ala Asn Arg
His Ala Arg Asn
His Asp Ile Ile
His Asp Ile Leu
His Asp Leu Ile
His Asp Leu Leu
His Glu Ile Val
His Glu Leu Val
His Glu Val Ile
His Glu Val Leu
His Gly Lys Arg
His Gly Arg Lys
His Ile Asp Ile
His Ile Asp Leu
His Ile Glu Val
His Ile Ile Asp
His Ile Leu Asp
His Ile Val Glu
His Lys Gly Arg
His Lys Asn Val
His Lys Arg Gly
His Lys Val Asn
His Leu Asp Ile
His Leu Asp Leu
His Leu Glu Val
His Leu Ile Asp
His Leu Leu Asp
His Leu Val Glu
His Asn Lys Val
His Asn Val Lys
His Arg Gly Lys
His Arg Lys Gly
His Val Glu Ile
His Val Glu Leu
His Val Ile Glu
His Val Lys Asn
His Val Leu Glu
His Val Asn Lys
Ile Ala Phe Phe
Ile Asp His Ile
Ile Asp His Leu
Ile Asp Ile His
Ile Asp Leu His
Ile Glu His Val
Ile Glu Val His
Ile Phe Ala Phe
Ile Phe Phe Ala
Ile His Asp Ile
Ile His Asp Leu
Ile His Glu Val
Ile His Ile Asp
Ile His Leu Asp
Ile His Val Glu
Ile Ile Asp His
Ile Ile His Asp
Ile Leu Asp His
Ile Leu His Asp
Ile Thr Thr Tyr
Ile Thr Tyr Thr
Ile Val Glu His
Ile Val His Glu
Ile Tyr Thr Thr
Lys Gly His Arg
Lys Gly Arg His
Lys His Gly Arg
Lys His Asn Val
Lys His Arg Gly
Lys His Val Asn
Lys Asn His Val
Lys Asn Val His
Lys Pro Pro Arg
C22H40N8O5 (496.31215100000003)
Lys Pro Arg Pro
C22H40N8O5 (496.31215100000003)
Lys Arg Gly His
Lys Arg His Gly
Lys Arg Pro Pro
C22H40N8O5 (496.31215100000003)
Lys Val His Asn
Lys Val Asn His
Leu Ala Phe Phe
Leu Asp His Ile
Leu Asp His Leu
Leu Asp Ile His
Leu Asp Leu His
Leu Glu His Val
Leu Glu Val His
Leu Phe Ala Phe
Leu Phe Phe Ala
Leu His Asp Ile
Leu His Asp Leu
Leu His Glu Val
Leu His Ile Asp
Leu His Leu Asp
Leu His Val Glu
Leu Ile Asp His
Leu Ile His Asp
Leu Leu Asp His
Leu Leu His Asp
Leu Thr Thr Tyr
Leu Thr Tyr Thr
Leu Val Glu His
Leu Val His Glu
Leu Tyr Thr Thr
Asn His Lys Val
Asn His Val Lys
Asn Lys His Val
Asn Lys Val His
Asn Val His Lys
Asn Val Lys His
Pro Lys Pro Arg
C22H40N8O5 (496.31215100000003)
Pro Lys Arg Pro
C22H40N8O5 (496.31215100000003)
Pro Pro Lys Arg
C22H40N8O5 (496.31215100000003)
Pro Pro Gln Arg
Pro Pro Arg Lys
C22H40N8O5 (496.31215100000003)
Pro Pro Arg Gln
Pro Gln Pro Arg
Pro Gln Arg Pro
Pro Arg Lys Pro
C22H40N8O5 (496.31215100000003)
Pro Arg Pro Lys
C22H40N8O5 (496.31215100000003)
Pro Arg Pro Gln
Pro Arg Gln Pro
Gln Pro Pro Arg
Gln Pro Arg Pro
Gln Arg Pro Pro
Arg Gly His Lys
Arg Gly Lys His
Arg His Gly Lys
Arg His Lys Gly
Arg Lys Gly His
Arg Lys His Gly
Arg Lys Pro Pro
C22H40N8O5 (496.31215100000003)
Arg Pro Lys Pro
C22H40N8O5 (496.31215100000003)
Arg Pro Pro Lys
C22H40N8O5 (496.31215100000003)
Arg Pro Pro Gln
Arg Pro Gln Pro
Arg Gln Pro Pro
Thr Ile Thr Tyr
Thr Ile Tyr Thr
Thr Leu Thr Tyr
Thr Leu Tyr Thr
Thr Thr Ile Tyr
Thr Thr Leu Tyr
Thr Thr Tyr Ile
Thr Thr Tyr Leu
Thr Tyr Ile Thr
Thr Tyr Leu Thr
Thr Tyr Thr Ile
Thr Tyr Thr Leu
Val Glu His Ile
Val Glu His Leu
Val Glu Ile His
Val Glu Leu His
Val His Glu Ile
Val His Glu Leu
Val His Lys Asn
Val His Leu Glu
Val His Asn Lys
Val Ile Glu His
Val Ile His Glu
Val Lys His Asn
Val Lys Asn His
Val Leu Glu His
Val Leu His Glu
Val Asn His Lys
Val Asn Lys His
Tyr Ile Thr Thr
Tyr Leu Thr Thr
Tyr Thr Ile Thr
Tyr Thr Leu Thr
Tyr Thr Thr Ile
Tyr Thr Thr Leu
11-trans-LTD4
C25H40N2O6S (496.26069400000006)
GS 1500
14,15-LTD4
C25H40N2O6S (496.26069400000006)
3-alpha,20-alpha-dihydroxy-5-beta-pregnane 3-glucuronide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
APGPR
Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake. Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake.
Anabsinthin
(3b,16b,20R)-Pregn-5-ene-3,16,20-triol 3-glucoside
2-[(6,7-Dimethoxy-1,2,3,4-tetrahydro-1-isoquinolinyl)methyl]-3-ethyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline 5-oxide
C29H40N2O5 (496.29370700000004)
Leukotriene D4
C25H40N2O6S (496.26069400000006)
A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and a L-cysteinylglycinyl group at position 6 (6R).
ST 21:0;O2;GlcA
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
4-[2-[4-[2-(4-anilinophenyl)propan-2-yl]phenyl]propan-2-yl]-N-phenylaniline
1-[6-amino-2-[[1-[2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
C22H40N8O5 (496.31215100000003)
1,1,3,3,3,3-hexamethylindotricarbocyanine tetrafluoroborate
(4R,15R)-11β,15-Dihydroxykaur-16-en-18-oic acid [β-D-glucopyranosyl] ester
(9xi,11alpha,17xi,22S)-2,3,11,14,20,22,25-heptahydroxycholest-7-en-6-one
(1R,2S,3S,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2-amino-2,7-dideoxy-D-glycero-alpha-D-gluco-heptopyranoside
C20H40N4O10 (496.27443000000005)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
(2R,3S,4S,5R,6R)-2-(1-aminoethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol
C20H40N4O10 (496.27443000000005)
2-Palmitoyl-sn-glycero-3-phosphoserine
C22H43NO9P- (496.2675298000001)
9-[(E)-4-[(6S)-2-[(1S,2S,3S)-1,3-dihydroxy-2-methylbutyl]-7-oxo-3,4-dihydro-2H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyl]oxynonanoic acid
9-[(E)-4-[(6S)-4-hydroxy-3-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]-5-oxo-2H-pyran-6-yl]-3-methylbut-2-enoyl]oxynonanoic acid
Methyl (Z)-3-[3-[cyclohexanecarbonyl-[[4-[4-(dimethylamino)phenyl]phenyl]methyl]amino]phenyl]prop-2-enoate
6-[2-Amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
C25H40N2O6S (496.26069400000006)
tert-butyl 4-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamoyloxy]piperidine-1-carboxylate
1-Palmitoyl-sn-glycero-3-phosphoserine(1-)
C22H43NO9P- (496.2675298000001)
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(1,4,13-trihydroxy-12,12-dimethyl-6-propan-2-yl-5-tricyclo[9.4.0.03,8]pentadeca-3,5,7-trienyl)oxy]oxane-3,4,5-triol
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
2-[(3alpha-Hydroxy-7,24-dioxo-5beta-cholan-24-yl)amino]ethane-1-sulfonate
C26H42NO6S- (496.2732692000001)
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
1-[(4S,7S,8R)-5-benzyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
4-[(2E,7S,8E,10E,13R,14R,16E,18E)-14-ethyl-7,13-dihydroxy-2,16,18-trimethylicosa-2,8,10,16,18-pentaenoyl]-2-methylidene-5-oxo-2,5-dihydro-1H-pyrrol-3-olate
C30H42NO5- (496.30628220000006)
4-[(1R,2R,4aS,5S,8aR)-2-[(2R,3R,5E,7E)-3-ethyl-2-hydroxy-5,7-dimethylnona-5,7-dien-1-yl]-5-hydroxy-1-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-2-methylidene-5-oxo-2,5-dihydro-1H-pyrrol-3-olate
C30H42NO5- (496.30628220000006)
(1S,3R,6R,8R,9R,11R,14S,15S,19R,20R)-8-ethyl-9,15-dihydroxy-3,4,6,20-tetramethyl-21,23-dioxo-24-azapentacyclo[20.2.1.0(1,6).0(11,20).0(14,19)]pentacosa-4,12,22(25)-trien-25-olate
C30H42NO5- (496.30628220000006)
methyl (1S,12R,14S,15E)-12-[3-(2-aminoethyl)-1H-indol-6-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraene-18-carboxylate
[(2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 8-methylnonanoate
C22H40O12 (496.25196400000004)
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
1-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
C28H40N4O4 (496.30494000000004)
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-N-[3-(dimethylamino)propyl]-3-(hydroxymethyl)-6-oxo-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H35F3N4O3 (496.26611160000004)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridine-2-carbonyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(4R,7S,8S)-5-benzyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
(2S,3S,3aR,9bR)-7-[4-[dimethylamino(oxo)methyl]phenyl]-3-(hydroxymethyl)-N-(2-methoxyethyl)-6-oxo-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridine-2-carbonyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
1-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(pyridine-3-carbonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
(2R,3R,3aS,9bS)-N-[3-(dimethylamino)propyl]-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-propanoyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-7-[4-(dimethylcarbamoyl)phenyl]-3-(hydroxymethyl)-N-(2-methoxyethyl)-6-oxo-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
1-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
1-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
C28H40N4O4 (496.30494000000004)
1-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
C28H40N4O4 (496.30494000000004)
1-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
C28H40N4O4 (496.30494000000004)
1-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N,1-dimethyl-6-indolecarboxamide
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(phenylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
C28H40N4O4 (496.30494000000004)
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
C28H40N4O4 (496.30494000000004)
1-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
C28H40N4O4 (496.30494000000004)
1-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
C28H40N4O4 (496.30494000000004)
1-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[(4-phenoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-morpholinyl)ethanone
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-N-[3-(dimethylamino)propyl]-3-(hydroxymethyl)-6-oxo-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H35F3N4O3 (496.26611160000004)
(2S,3S,3aR,9bR)-N-[3-(dimethylamino)propyl]-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1-(1-oxopropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
2-[(3-Heptanoyloxy-2-octanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Dodecanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Acetyloxy-2-tridecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Hexanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Decanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Butanoyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
Absinthin
Absinthin is a dimeric sesquiterpene lactone that is produced by the plant Artemisia absinthium (Wormwood). The bitter tasting constituent of Absinthe. It has a role as a plant metabolite and an anti-inflammatory agent. It is a sesquiterpene lactone, a triterpenoid and an organic heteroheptacyclic compound. Absinthin is a natural product found in Artemisia genipi, Artemisia annua, and other organisms with data available. A dimeric sesquiterpene lactone that is produced by the plant Artemisia absinthium (Wormwood). The bitter tasting constituent of Absinthe.
2beta,3beta,5beta,14,20,22R,25-heptahydroxycholest-7-en-6-one
Pregnanediol 3-glucuronide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
APGPR Enterostatin
Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake. Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake.
2,3,14-trihydroxy-10,13-dimethyl-17-(2,3,6,7-tetrahydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one
1-(9Z-heptadecenoyl)-glycero-3-phospho-(1-sn-glycerol)
eoxin D4
C25H40N2O6S (496.26069400000006)
A leukotriene that is the 14R-(S-cysteinylglycyl),15S-hydroxy derivative of (5Z,8Z,10E,12E)-icosa-7,9,11,14-tetraenoic acid.